---
document_datetime: 2025-08-26 14:14:13
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zykadia-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: zykadia-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 6.5475079
conversion_datetime: 2025-12-20 01:25:45.259429
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Zykadia

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific informationafterauthorisation(archive).

| Applicationnumber    | Scope                               | Opinion/ Notification 1 issued on   | Commission Decision Issued²/ amendedon   | Product Information affected3   | Summary   |
|----------------------|-------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation typeIA_IN/ | A.5Changeinthenameand/oraddressof a | 26/08/2025                          |                                          | Annex II and                    |           |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3SmPC(Summary ofProductCharacteristics),AnnexII,Labelling,PL(PackageLeaflet).

2 A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics, annexII, labelling,package leaflet).The CDisissuedwithintwomonths of the opinionforvariationsfallingunderthescope ofArticle23.1a(a)ofRegulation(EU)No.712/2012,orwithinoneyearforotherprocedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|                                       | manufacturer/importer of the finished product (including batch release or quality control testing sites)-A.5.a The activities for which the manufacturer/importer is responsible includebatchrelease-Accepted                                                                                                                                                                                                                                       |            |     | PL   | EMA/VR/0000293040   |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|------|---------------------|
| Variation type IA /                   | B.II.d.1 Change in the specification parameters and/or limits of the finished product - B.II.d.1.c Addition of a new specification parameter to the specification with its corresponding test method - Accepted B.II.d.2Change in test procedurefor the finished product-B.II.d.2.a Minor changes to an approved test procedure - Accepted                                                                                                          | 11/03/2025 |     |      | EMA/VR/0000255419   |
| Variation type IA / EMA/VR/0000249758 | Thiswasanapplicationfor agroupof variations. B.III.1.bEuropeanPharmacopoeial TSE Certificate ofsuitabilityfor an active substance/startingmaterial/reagent/ intermediate/orexcipient-B.II1.1.b.3 Updatedcertificatefromanalready approved manufacturer- Accepted B.IIl.1.bEuropeanPharmacopoeial TSE Certificateofsuitabilityfor anactive substance/startingmaterial/reagent/ intermediate/or excipient-B.Il1.1.b.3 Updatedcertificatefromanalready | 13/02/2025 | N/A |      |                     |

<div style=\"page-break-after: always\"></div>

|                                          | approved manufacturer- Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |            |                 |
|------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----------------|
| Variation type IA / EMA/VR/0000247426    | This was an application for a group of variations. B.II.b.2.cReplacement or addition of a manufacturerresponsibleforimportation and/or batch release-B.I1.b.2.c.1 Not includingbatchcontrol/testing-Accepted A.ADMINISTRATIVECHANGES-A.7 Deletionofmanufacturingsitesforanactive substance,intermediateorfinishedproduct, packaging site, manufacturer responsible for batchrelease,sitewherebatchcontroltakes place,orsupplier of astartingmaterial, reagent or excipient (when mentioned in the dossier)*- Accepted A.ADMINISTRATIVECHANGES-A.7 Deletion of manufacturing sites for an active substance, intermediate or finished product, packagingsite,manufacturerresponsiblefor batchrelease，sitewherebatchcontroltakes place,orsupplierofastartingmaterial, reagent or excipient (when mentioned in the | 30/01/2025 | Annex II and PL |
| Variation type IA_IN / EMA/VR/0000247247 | This was an application for a group of variations. B.II.b.2.cReplacement or addition of a                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      | 29/01/2025 | Annex II and PL |

<div style=\"page-break-after: always\"></div>

manufacturerresponsibleforimportation and/or batch release - B.1I.b.2.c.1 Not includingbatchcontrol/testing-Accepted

A.ADMINISTRATIVE CHANGES-A.7 Deletionofmanufacturingsitesforanactive substance, intermediate or finished product, packaging site, manufacturer responsible for batchrelease,site wherebatch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)*-Accepted

A.ADMINISTRATIVECHANGES-A.7 Deletion of manufacturing sitesfor an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place,orsupplier of astartingmaterial, reagent or excipient (when mentioned in the dossier)*-Accepted